Tower Health takes a scalpel to its doctors group


May 11—Tower Health on Monday announced a restructuring of a subsidiary that employs its physicians and has been posting outsized losses as the Berks County nonprofit undertook a dramatic — and expensive — expansion into the Philadelphia market.

The changes include the consolidation of some practices, the closure of others, and cancellation of employment contracts of some doctors.

"These changes are projected to impact up to 95 providers and 100 support staff, and we will communicate directly with these individuals over the coming weeks," according to the internal email from P. Sue Perrotty, Tower's interim president and chief executive. The number refers to those who could lose their jobs as well as those who could be transferred to other practices.

The note did not say how many doctors and others will lose their jobs. The restructuring, which includes physician pay changes, is expected to save $70 million.

The Tower Health Medical Group, which employs 890 doctors, including medical residents, had an operating loss of nearly $250 million on $206 million in revenue in the 12 months ended June 30, 2020. Results were not much better in the six months through December.

Overall, Tower said it had trimmed $101.7 million in expenses in the nine months ended March 31, which means it could be on track for an operating loss in the $300 million range for the fiscal year that ends June 30. That would be an improvement compared with Tower's $439 million operating loss last year.

Tower said its facilities have shown positive momentum starting in March in revenue and patient visits.

Monday afternoon, Tower management had a scheduled call with municipal bond investors, who are closely monitoring the amount of cash Tower has on hand to pay its day-to-day bills. That figure has been declining steadily. Tower has closed its investor calls to the media.

In March, Tower laid off 15 employees at St. Christopher's Hospital for Children, which it co-owns with Drexel University. A bond analyst at Fitch Ratings described the move as chipping away at the edges for a system that has a high debt load and massive, persistent losses.

"They need to make some draconian decisions," Kevin Holloran said at the time. He had recently downgraded Tower's credit rating by three notches to B+, deep in junk-bond territory.

Tower's path to financial peril started in 2017 when it paid $423 million in borrowed money for five money-losing community hospitals in Philadelphia, Chester, and Montgomery Counties and then spent at least $120 million to install a top-of-the-line electronic health records system.

Since Tower acquired those hospitals in Chestnut Hill, Coatesville, Jennersville, Phoenixville, and Pottstown, they have lost more than $460 million.

Tower and Drexel paid $58 million for St. Christopher's, split evenly, but the deal did not include the property, most of which is owned by a Philadelphia real estate investment firm.

Last fall, Tower's board launched an effort to sell those five hospitals and St. Christopher's, sparing only its "mother ship" Reading Hospital in West Reading.

After nothing satisfactory came of that, the board decided to look at whether a larger system might want to acquire all of Tower, which had nearly $2 billion in revenue in the year ended June 30, 2020.

Bids were due April 23.

Tower officials have said only that its board of directors received several "indications of interest," though it's likely that a couple of potential buyers were interested only in Reading Hospital, which would be difficult to sell outside of bankruptcy.

Perrotty told employees in an email last week that she expected the board to take until the end of June to "determine if a partnership option will best meet Tower Health's needs for the future."

___

(c)2021 The Philadelphia Inquirer

Visit The Philadelphia Inquirer at www.inquirer.com

Distributed by Tribune Content Agency, LLC.


Related Businesses
    - - Customer

    Copyright © 2024 by CreditRiskMonitor.com (Ticker: CRMZ®). All rights reserved.  You are not permitted to use this report or the information contained herein for any purpose not expressly permitted by CreditRiskMonitor.com, Inc. Except as expressly permitted by CreditRiskMonitor.com, Inc., you are not permitted, in whole or in part, to copy, alter, correct, adapt, translate, enhance, lease, sell, sublicense, assign, distribute, publish, otherwise make available to any third party, or prepare derivative works or improvements of this report or any of the information contained therein. You are not permitted to reverse engineer, disassemble, decompile, decode, or adapt the software, algorithms or other processes used to prepare this report, or otherwise attempt to derive or gain access to the source code of same. You agree not to remove, alter, obscure, combine or otherwise change any disclaimers, trademarks, copyrights, other intellectual property rights, proprietary rights, or other symbols, notices, marks, or serial numbers on or relating to any copy of the report or on marketing or other materials that CreditRiskMonitor.com, Inc. may provide to you. You will not use this report in any manner or for any purpose that infringes, misappropriates, or otherwise violates any right of any party, or that violates any applicable law.  
    The FRISK® scores, agency ratings, credit limit recommendations and other scores, analysis and commentary are opinions of CreditRiskMonitor.com, Inc. and/or its suppliers, not statements of fact, and should be one of several factors in making credit decisions.  Any reliance you place on the information in this report is strictly at your own risk. Except as expressly provided by CreditRiskMonitor.com, Inc., no warranties or representations of any type, including without limitation of results to be obtained, merchantability or fitness for a particular purpose, are made concerning any part of CreditRiskMonitor.com, Inc.’s service, including without limitation the FRISK® scores.  The information published above has been obtained from sources CreditRiskMonitor considers to be reliable.  CreditRiskMonitor.com, Inc. and its third-party suppliers do not guarantee or validate the accuracy and completeness of the information provided in this report, the underlying information input to create the FRISK® scores, and specifically do not assume responsibility for not reporting any information omitted or withheld.  By using this website, you accept the Terms of Use Agreement
    Contact Us: 845.230.3000
    Fundamental financial data concerning public companies may be provided by Refinitiv (click for restrictions)
    Tuesday, April 16, 2024